Prostate cancer detection with office based saturation biopsy in a repeat biopsy population.
about
When prostate cancer remains undetectable: The dilemmaCurrent status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsiesMultiparametric Magnetic Resonance Imaging and Ultrasound Fusion Biopsy Detect Prostate Cancer in Patients with Prior Negative Transrectal Ultrasound BiopsiesBudget impact model: epigenetic assay can help avoid unnecessary repeated prostate biopsies and reduce healthcare spending.Simulation optimization of PSA-threshold based prostate cancer screening policies.Repeat prostate biopsy strategies after initial negative biopsy: meta-regression comparing cancer detection of transperineal, transrectal saturation and MRI guided biopsy.Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging.Beyond diagnosis: evolving prostate biopsy in the era of focal therapy.Repeat Targeted Prostate Biopsy under Guidance of Multiparametric MRI-Correlated Real-Time Contrast-Enhanced Ultrasound for Patients with Previous Negative Biopsy and Elevated Prostate-Specific Antigen: A Prospective Study.Prostate-specific antigen in the early detection of prostate cancer.Prostate biopsy and anaesthesia: an overview.The role of prevalence in the diagnosis of prostate cancer.Saturation biopsy for detecting and characterizing prostate cancer.Saturation biopsies on autopsied prostates for detecting and characterizing prostate cancer.Effect of the number of biopsy cores on prostate cancer detection and staging.Management of rising prostate-specific antigen after a negative biopsy.Prostate cancer detection after a negative prostate biopsy: lessons learnt in the Cleveland Clinic experience.The epigenetic promise for prostate cancer diagnosis.Prostate saturation biopsy following a first negative biopsy: state of the art.Low incidence of prostate cancer identified in the transition and anterior zones with transperineal biopsy.Random biopsy: when, how many and where to take the cores?Effect of Oral Administration of Acetaminophen and Topical Application of EMLA on Pain during Transrectal Ultrasound-Guided Prostate Biopsy.Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting.Prostate biopsy in Switzerland: a representative survey on how Swiss urologists do it.A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy.Outcomes of transperineal template-guided prostate biopsy in 409 patients.Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy.DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy.Clinical-pathologic correlation between transperineal mapping biopsies of the prostate and three-dimensional reconstruction of prostatectomy specimens.Do additional cores from MRI cancer-suspicious lesions to systematic 12-core transrectal prostate biopsy give better cancer detection?Prostate atypia: clinical and pathological variables associated with cancer diagnosis on repeat biopsy.Role of magnetic resonance spectroscopic imaging ([¹H]MRSI) and dynamic contrast-enhanced MRI (DCE-MRI) in identifying prostate cancer foci in patients with negative biopsy and high levels of prostate-specific antigen (PSA).The morbidity of transperineal template-guided prostate mapping biopsy.Metabolomic signatures of aggressive prostate cancer.RETRACTED: Histopathology reports of findings of prostate needle biopsies
P2860
Q26795515-A25D1208-68E7-4FE9-AA20-9DE678DA013BQ27001055-0ACBB140-1F0F-4163-8069-FB8F1106A735Q30047599-8ED27B60-6591-4F88-AAA9-DCCCE4F3F53AQ33652793-3C9EE2F9-F821-4DF4-B251-B920387F12D6Q34149637-A7D47419-EAD3-49AA-B904-0ED89BD662CEQ34608622-AB90F62E-6657-427D-928C-0002DA2F3CE3Q35354750-FF684D49-CD8D-4651-BB1F-9063C837DE57Q35550202-3191F70B-6EF1-448D-B026-D52EF7313B10Q35665891-019C440B-C2E6-43D7-BA19-BF1CE21A99CCQ35840271-35E031CE-D1AB-44EF-ABAA-0FC5B53A994DQ36194992-4634A2F0-206C-4DF4-8965-6A4FCE1BB8D2Q36555644-B2C07CE0-237D-4105-9782-0E40BE4B1629Q36788576-FCEC98B4-C921-4165-B4FF-F311EF000AEFQ37240462-37BCAEC3-1E4F-4C28-95C8-0BE5802CE12FQ37707378-26CE0677-D25D-4578-A9B0-0904178E1BD8Q37846119-818AA1C4-E884-4774-AE6A-5675880F5770Q37892629-E0C4E43B-9648-466F-8295-3B9CB8ECDDD4Q37967574-10696CE6-3C75-4276-B9D6-1EDBC83373D6Q38027698-0B3CCF0D-D033-4B2B-AF65-56C5BF46C376Q38160496-BB4537A6-EA49-41EA-9E0D-FE9F19B7FD3CQ38218443-4D4B9B05-62E6-4B2C-8706-A2E7DCB35FDCQ39260597-AD04483B-AE52-4A1F-BA56-3048B1AE8ED8Q39477975-DABFAA31-2951-4DCE-9822-96CD3C8C00BEQ39813133-C95EB5FD-D40B-4305-ACA8-839F01F08D45Q39999913-D47F872A-A4A9-4FE5-9EE7-569AC91197D4Q40102454-B4086F67-B453-4130-95B1-0AF1330A3704Q40381262-57566E50-263D-467D-BDC6-2B953F23A0DFQ42676794-EAF31DD3-71B5-496C-A512-5ECD30EB6F88Q43196725-C3BD0D89-8C2E-4F52-BEF4-D2D3415F14AFQ43905409-7A63641A-1A91-4404-9794-6E2B1D8063F5Q44399197-914CD28D-EF40-4C5F-A019-AEBF041F85B1Q45568949-AF9631D7-3832-4294-8C4E-225BA331E7AEQ46715044-37904A83-1BFE-43B8-B4CC-3A7884191FFDQ50860265-D5F186C6-F11E-457D-888B-01ABE165646EQ56533035-5453C5DB-E374-4D91-8E6D-937E73A9D0D7
P2860
Prostate cancer detection with office based saturation biopsy in a repeat biopsy population.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Prostate cancer detection with ...... in a repeat biopsy population.
@en
Prostate cancer detection with ...... in a repeat biopsy population.
@nl
type
label
Prostate cancer detection with ...... in a repeat biopsy population.
@en
Prostate cancer detection with ...... in a repeat biopsy population.
@nl
prefLabel
Prostate cancer detection with ...... in a repeat biopsy population.
@en
Prostate cancer detection with ...... in a repeat biopsy population.
@nl
P2093
P1476
Prostate cancer detection with ...... in a repeat biopsy population.
@en
P2093
Amit Patel
Craig D Zippe
J Stephen Jones
John C Rabets
P356
10.1097/01.JU.0000132134.10470.75
P407
P577
2004-07-01T00:00:00Z